Drug pricing hearings

Pharma’s Bad Behaviors Exposed in Congressional Testimony

In the first of two days of Congressional testimony, top drug company CEOs responded to a pair of bombshell Congressional Oversight committee reports that revealed how pharma regularly uses anticompetitive tactics to raise drug prices, boost profit and fuel executive bonuses. Read more.

In Day 2 of Testimony, Pharma Execs Struggle to Answer Tough Questions on Unsustainable Drug Prices

A trio of drug company executives faced intense scrutiny on Thursday from Congressional members over their business strategies — exposed in committee reports — to profiteer and profit gouge. Read more.